Pat Barry

Pat Barry

Chief Commercial OfficeratIndivior Pharmaceuticals· In the 2025 proxy

Pay in FY2025Indivior Pharmaceuticals stock +188.7% the same year

Pat Barry was paid $4.9M in FY2025 (Dec). Indivior Pharmaceuticals stock rose 188.7% that year.

Pay$100 in the stock at the end of FY24 → $289
Pay is from the Summary Compensation Table of each Indivior Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Indivior PharmaceuticalsPublic company · 1 yr
    • Chief Commercial Officer2025 – Present · 1 yrStock in role +190%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?